Marker Therapeutics, Inc. (MRKR): auditor change — Marker Therapeutics changes auditor from Marcum to CBIZ CPAs; no disagreements

Marker Therapeutics, Inc.

Marcum LLP resigned as auditor on August 6, 2025; CBIZ CPAs engaged for FY 2025.
Marcum's prior reports contained a going concern explanatory paragraph but no adverse opinions.
No disagreements or reportable events occurred during Marcum's tenure through 2025.
Change follows CBIZ's acquisition of Marcum's attest business effective November 1, 2024.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of Marker Therapeutics, Inc..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

On August 6, 2025, Marcum resigned as the Company’s independent registered public accounting firm and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marker Therapeutics, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025

View on SEC.gov

12 auditor changes filed in the last 30 days. Browse all auditor changes →

Marker Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-076834

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.